Lecture - Blood pressure: How do recent trial outcomes impact our hypertension management?
This lecture was part of a Cardiovascular Risk Master Class 'CV Risk Management 2017: Applying the latest insights to clinical care' held on April 8, 2017 in Buenos Aires, Argentina
Educational information
The overall educational objectives of the Cardiovascular Master Class are:
- To review the epidemiology and current guidelines on the diagnosis, management, and treatment of patients at increased CV risk in Argentina.
- To review new data on the pathophysiology of coronary artery disease and stroke and its relevance to treatment strategies and outcomes.
- To understand the medical need for intensive lipid and hypertension management in patients at high CV risk, such as DM and metabolic syndrome.
- To understand the pharmacologic and clinical rationale for various treatment options in the patients with increased CV risk and integrate scientific evidence from key clinical trials into clinical practice.
- To develop a consensus on practical guidelines for day-to-day management of high risk patients.
Disclosures
Prof. John E Deanfield is Professor of Cardiology, Director, National Centre for Cardiovascular Prevention and Outcomes - University College London – United Kingdom
Funding
The master class is supported by an unrestricted educational grant provided by Pfizer Inc
The content is aimed for medical professionals. To view this item member registration is needed. Register for free to get unlimited access to our educational resources.
The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.
Share this page with your colleagues and friends: